As clinical diagnostics become a central force in shaping therapies and driving innovation, healthcare leaders must prepare ...

Last month, the Trump administration announced major plans to slash prices of GLP-1s, including Ozempic, Wegovy, Zepbound, and Mounjaro. The agreement will lower prices of these medications from ...

The Food and Drug Administration (FDA) issued a public warning about compounded topical versions of a popular hair loss drug sold through telehealth platforms. However, the agency has not approved any ...